Evaluation of an electronic health record-supported obesity management protocol implemented in a community health center: a cautionary note
Primary care clinicians are uniquely positioned to help reduce obesity, since 80% of the public sees their provider annually. [5] [6] [7] [8] [9] [10] [11] [12] However, numerous studies indicate that obesity counseling in primary care settings remains rare. [13] [14] [15] [16] [17] [18] [19] [20] We examined whether implementation of an obesity intake protocol and an electronic health record (EHR) obesity management form could improve evidence based obesity practices and outcomes in a Federally Qualified Health Center (FQHC).
The Centers for Medicare and Medicaid Services endorses a 5A's approach to obesity management, whereby the clinician Assesses BMI, Advises weight loss, Agrees on behavior change goals, Assists in developing action plans, and Arranges follow-up. 21 The EHR, now utilized in 72% of office-based practices, 22 holds the potential to deliver reminders and prompts that increase implementation of the 5A's. In the protocol studied here, intake personnel's entry of the patient's height and weight into the EHR triggered an automated assessment of obesity. Notification of obesity in the patient's record was designed to prompt the clinician to add obesity to the problem list, advise weight loss, and reach agreement with the patient about specific behavior change goals and action plans.
Implementing obesity intervention via the EHR holds good potential for generalization because such interventions "operate in the context of routine clinical care." 23 However, it remains unclear whether the EHR can facilitate changes in clinician management of obesity that translate to meaningful change in patient outcomes. 24 To address this gap in the literature, we examined implementation of a 5A's based intake protocol and EHR weight management form designed to assist clinicians in identifying and managing adult obesity. We evaluated impact across three studies, involving different samples. In the Clinician Study, we examined whether the new weight management form and protocol improved self-reported weight-loss counseling and confidence about managing patients' obesity among a select sample of clinicians in the practice. In the Population Study, we examined the obesity management behaviors of all clinicians and the BMI of all patients in the practice 6 months before and after introduction of the form and protocol. We hypothesized that the intervention would improve clinician management of patients' obesity, as evidenced by an increase in the proportion of patients whose obesity was documented on their EHR Problem List. Exploratory hypotheses were that introduction of the obesity protocol and form would improve clinician ordering of appropriate obesity-related laboratory tests and would lower patient BMI. Lastly, in the Exposure Study, we compared patient outcomes among patients whose EHR documentation demonstrated that they and their clinician had been exposed to the EHR obesity form, vs matched controls who had not been exposed. We hypothesized that exposure to the form would improve clinician obesity management behaviors (e g, provision of weight-loss counseling, health promotion behavioral referrals, ordering appropriate obesity-related laboratory tests), and reduce patient BMI.
PROCEDURE AND DESIGN
Clinicians from a FQHC in West Chicago provided advice on the design and content of the new weight management protocol. The Problem List button was enlarged and repositioned to facilitate the inclusion of obesity. A checklist of behavior change goals was added to the EHR, given evidence that successful obesity management is linked to agreement on specific attainable behavioral goals. 25 (Supplementary Appendix A). Once the new form was drafted, clinicians from the FQHC and health informaticians from the Alliance of Chicago provided feedback that informed the final design of the form. After content and flow charts were agreed upon, informatics staff added the form to the EHR. Following a single training session that introduced clinic staff to the content of the form, its location in the EHR, and details of the new protocol, Northwestern University and FQHC staff officially released the form for general use at the FQHC on July 11, 2012.
The nurse or medical assistant (MA) identified obese patients by entering height and weight data at intake. According to the new obesity management protocol, after rooming the patient, the nurse or MA helped him or her to complete an English or Spanish hardcopy version of a behavior change goal checklist prior to the clinician's arrival. The clinician then discussed weight management with the patient while checking off on the EHR form the goals that the patient endorsed on the hardcopy version of the checklist. The endorsed goals auto-populated under the Health Goals section of the form and remained there to be reviewed in future visits (Appendix B).
CLINICIAN STUDY Methods

Sample
Clinicians were recruited from a FQHC in West Chicago that served predominantly low-income, Hispanic adults. The clinic staff included approximately 40 clinicians from medicine, nursing, and psychology that provided medical services to nearly 7000 patients, 67% of whom are Spanish-speaking. The sample for the clinician study comprised 12 respondents who answered the FQHC medical director's request for clinicians to test the impact of the intervention. The 12 respondents were surveyed 6 months before and 6 months after the addition of the form and protocol (Figure 1 ).
Measures
Clinician Surveys. The clinician survey, designed specifically for this study, was approved by the Institutional Review Boards of Northwestern University and the FQHC. The survey (Appendix C) assessed clinicians' demographics, self-efficacy about managing obesity, and satisfaction with the EHR.
The 52-item survey included multiple choice, open-ended items, and 5-point Likert scale items asking how often the clinician performed obesity-related management practices (1 ¼ Always, 5 ¼ Never) and their endorsement of specific attitudes about obesity and about the EHR (1 ¼ Strongly Agree, 5 ¼ Strongly Disagree).
Clinicians completed baseline surveys during a staff meeting 6 months before the form was added to the EHR. Prior to distributing the surveys, the research coordinator explained the study's aims and rationale and obtained verbal consent from all participating clinicians. The coordinator then resurveyed the same clinicians 6 months after the form was added to the EHR. Clinicians were compensated US$100 for completing both surveys.
Statistical Analyses
Paired t-tests were used to compare survey responses before and after installation of the form, with a Bonferroni correction to control for the familywise error rate. Analyses were conducted using IBM SPSS Statistics Version 21.
Results
Demographics
All 12 members of the clinician sample completed both presurveys and postsurveys. Most of the clinician sample were female (10/12) and physicians (7/12) ; others in the sample were nurse practitioners. Most in the sample (9/12) had used the EHR for more than 2 years.
Clinician Surveys
As shown in Table 1 , clinicians self-reported that their practice of assessing physical activity, diet, and obesity-related medical conditions increased after, as compared to before, the addition of the obesity intake protocol and weight management form. Although their attitudes about treating obesity showed no significant change, clinicians also reported that the new protocol and EHR form made it easier to identify obese patients and increased their confidence about managing obesity.
POPULATION STUDY
To evaluate the population-level impact of the EHR form and obesity intake protocol on clinician management of obesity and patient outcomes, we examined change from 6 months before to 6 months after installation of the form among all patients seen for health visits at the Figure 1 . Pre = 6-month period before the weight management form was implemented (Jan 11, 2012 to July 11, 2012). Post = 6-month period after the weight management form was implemented (July 12, 2012 to Jan 12, 2013) FQHC during this period ( Figure 1 ). Specifically, we tested the hypotheses that, among all patients, the form and protocol would improve EHR documentation of obesity on the Problem List as well as laboratory tests related to obesity and would reduce the BMI of the patient population.
Methods
Sample
The sample included all patients from the FQHC with a recorded BMI entry in the 6 months before (January 1, 2012 to July 11, 2012) (n ¼ 6624) or after (July 12, 2012 to January 12, 2013) (n ¼ 6960) the addition of the form and protocol. Patients included in the analyses were required to be 18-years-old through 65-years-old and to have been seen by a clinician at least once during both the 6-month prephase and the 6-month postphase. Patient information was de-identified and shared with Northwestern University staff via encrypted databases.
Measures
Electronic Health Record Data. Demographic data (age, ethnicity) and outcomes body mass index (BMI) were extracted from the EHR. Algorithmic computation of a valid BMI required both weight and height to have been manually entered during the patient's visit. Additional outcomes were clinician-initiated ordered obesity-related laboratory tests for glycosylated hemoglobin glycated hemoglobin (A1C), thyroid stimulating hormone (TSH), and lipids. We also extracted whether obesity was on the Problem List.
Statistical Analyses
To assess whether the intervention lowered the proportion of obesity in the entire clinic population, the proportion of patients classified as obese vs other weight categories patients before and after the addition of the form was compared by a chi-square test. The most recent BMI recording in each assessment period (preassessment and postassessment) was taken as the measure of BMI for each patient. Among obese patients only, the prefrequency and postfrequency of documented laboratory tests, including A1C, TSH, and lipid panel orders was compared by t-tests. A chi-square test was used to compare how frequently obesity status was on the Problem List before vs after inclusion of the form. All data analysis was conducted using IBM SPSS Statistics Version 21.
Results
Demographics
As shown in Table 2 , there were no differences in patient age or ethnicity before vs after the addition of the obesity intake protocol and EHR form. Table 2 shows that clinician inclusion of obesity on the Problem List was no greater for obese patients after, as compared to before, introduction of the obesity protocol and EHR form (x 2 (1, N ¼ 4768) ¼ 0.15, P > 0.05). There was also no consistent change in obesity-related lab orders. Clinician test orders for obese patients decreased from 12.8% through 9.1% for TSH (t ¼ À2.61, P < 0.05), but orders for A1C (25.5% through 23.5%; t ¼ À1.67, P > 0.05) and lipid panel (20.5% through 21.0%; t ¼ 0.71, P > 0.05) showed no significant change.
Documentation and Distribution of BMI
Although the proportion of normal weight individuals in the patient population increased from pre to post, the proportion of those with obese and overweight BMI also increased. The observed increase of patients in all BMI categories was accompanied by a decreased proportion of those with invalid BMIs (ie, those not documented because of missing entries for weight, height, or both). Hence, the increased number of patients with a valid BMI entry in the EHR was distributed across all weight categories (see Figure 2) . Weight was documented in the EHR on 99.1% of patient visits both before and after the addition of the obesity intake protocol and form. However, documentation of height increased from 69.6% through 79.2% during the same time period (x 2 (1, N ¼ 5491) ¼ 164.18, P < 0.05). Finally, examination of how many patients had data entered into the EHR obesity form showed that only a small number (n ¼ 55) had been exposed to the form. To assess whether the intervention held any potential to influence clinician and patient behaviors, we examined prechange to postchange on the subsample of patients that was exposed to the form ("Exposure Study" section).
EXPOSURE STUDY
The Exposure Study is a case-control study that tested the hypothesis that the new form and protocol increased EHR-documented ordering of obesity-related laboratory tests, health promotion behavioral referrals, weight-loss counseling, and decreased BMI among patients who were exposed to the form in comparison to those who were not exposed to the form.
Methods
Sample
The sample in this case-control study was obese patients (cases) who were exposed to the form and completed the Health Behavior Change Checklist and matched obese patients (controls) who were not exposed to the form or the Checklist. Both cases and controls needed to have been seen by a clinician for health care visits at least once during both the 6-month phase preinstallation of the obesity management EHR form and protocol and the 6-month postphase. Patients who were pregnant during the year-long study time frame were excluded (n ¼ 9), 25 yielding a sample of 46 cases. Cases were stratified into four groups based on sex and BMI. Controls were randomly selected from the same four demographic subgroups in the remaining patient population so as to match the proportion of cases from each subgroup. Patient data were compiled by Alliance informatics staff, de-identified, and shared with Northwestern University staff via encrypted databases.
Measures Electronic Health Records. The EHR records of cases and controls were evaluated for patient demographics and outcomes for the period 6 months prior to and 6 months following addition of the form. Patient variables were age, sex, weight, and BMI. Clinician obesity management variables were documentation of obesity on the problem list, health promotion behavioral referrals, and obesity-related laboratory orders, including A1C, TSH, and lipid panels. Also coded was weightloss counseling (ie, discussion of weight, diet, and physical activity) as documented by clinicians in an EHR office visit summary note that consolidated all procedures conducted during any health visit. Patient willingness to engage in specific health behavior change goals was measured by the Health Behavior Change Checklist completed during the visit and that the provider entered into the EHR form (Appendix A).
Statistical Analyses
Two-way repeated measures analyses of variance [with form exposure as the between-subjects factor and time (pre/post inclusion of the form) as 2) (t ¼ 3.03, P < 0.01), we controlled for age in all analyses.
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Electronic Health Record Data
As Table 3 shows, documentation of obesity on the Problem List was nearly universal (98% through 100%) for both cases and controls even prior to the obesity intervention and did not change over time (x 2 (1, N ¼ 46) ¼ 0.95, P > 0.05). The provision of weight-loss counseling did increase significantly after exposure to the form among cases, but not among controls (F (1,81) ¼ 13.33, P < 0.001, partial g 2 ¼ 0.14) ( Table 3 ). For both cases and controls, BMI decreased over time but the between group difference was not significant (F (1,46) Analyses of obesity-related laboratory orders showed that A1C orders increased over time for both obese cases and controls, (F (1,93) ¼ 7.00, P ¼ 0.01, partial g 2 ¼ 0.07) and did not differ between them (F (1,93) 
No other lab orders, including lipid panel, TSH, and health promotion behavior referrals, changed over time, nor were there differences between groups.
Health Behavior Change Checklist Among cases, nearly half (n ¼ 22) endorsed one or two goals. The most frequently endorsed goals were "Eat more healthy foods" and "Increase physical activity" (Table 4 ). Seventeen percent of cases did not endorse any healthy behavior change goals.
DISCUSSION
Results of this study show potential for an EHR-based obesity intervention to improve clinicians' confidence and care practices regarding obesity, but they also demonstrate many barriers to reaching an entire patient population. Clinicians reported that the form increased their performance of obesity-related behavioral and medical assessments and their confidence in managing patients' obesity. However, analyses of the records of all clinic patients failed to show clinically meaningful change in documentation of obesity on the Problem List or of obesity-related orders. What initially appeared to be a favorable increase in the proportion of normal weight patients after introduction of the form was offset by an increase in the proportion of overweight and obese patients. These apparently positive changes in the distribution of patients' BMIs were accounted for spuriously by increased recording of patients' height, which enabled the EHR's algorithms to validly compute BMI and decreased invalid entries.
Further analyses revealed that only a very small percentage of patients in the clinic was exposed to the EHR form. Exposed patients were twice as likely to receive weight-loss counseling after the form and protocol were introduced, as compared to before. They were also more likely than matched controls to receive weight-loss counseling, although neither their laboratory orders nor their BMI changed differentially.
It is noteworthy that in the Exposure study, the form and protocol facilitated clinicians' weight-loss counseling, but had less effect on biomedical obesity practices, such as laboratory test orders. Presumably, the selective impact on behavioral obesity practices occurred because the Health Behavior Checklist given to the patient and entered into the EHR by the clinician prompted agreement about reaching these specific behavioral goals.
A limitation in interpreting outcomes of the Clinician Study is that our recruitment method may have biased the sample towards clinicians with high motivation and interest in obesity management. A Table 4 : Patient-endorsed goals from the health behavior change checklist
Goal Total Goals Endorsed
Write down what I eat 6
Eat more healthy foods 32
Eat less unhealthy foods 19
Increase physical activity 45
Decrease sitting time 8
Create a regular eating routine 13
Go to a park district recreation program 5
See a health behavior educator 3
See a "promotora" at La Vida Sana Community Program 8 limitation of the Population Study is that the inclusion criterion requiring two health visits within the data collection time frame of one year might have led to recruiting less healthy patients relative to those who had only one or no health visits during the year. A limitation in interpreting outcomes of the Exposure Study is that, because data were anonymized, we do not know how many different clinicians were involved in exposing the 46 patients who encountered the EHR obesity form. We cannot determine, for example, whether many clinicians used the form a few times or a single clinician used the form many times.
RESEARCH AND APPLICATIONS
Finally, most EHR-based intervention studies to modify clinician behaviors observe performance outcomes for up to 1 year following implementation of the intervention.
26-29 The 6-month postintervention follow-up duration we used may have been insufficiently long to detect significant changes in clinician behavior that could drive change in patient weight outcomes.
These findings and limitations are in line with other research on EHR-based obesity interventions. To our knowledge, only four such interventions for adult obesity have been examined. Those interventions included features that we also used to address the first two of the 5A's (Assess obesity and Advise weight loss) by including automated BMI calculations and prompts to add obesity to the problem list. 30 The current study was unique in activating clinicians also to perform two of the later and more impactful obesity A's (Agree on behavior change goals and Assist in developing action plans) via the use of a health behavior change checklist. It was also unique in examining not only clinician behavior but also patient outcomes, 30 a category of results that has rarely been assessed in EHR-based interventions for health behaviors. 27, 28 Although our study is unique in assessing patient weight outcomes, it is also a cautionary tale. The research illustrates how many different ways we could have been misled in our conclusions regarding whether an EHR-based obesity intervention is helpful for population-level obesity treatment. First, we might have accepted at face value the clinicians' self-appraisals that the form improved clinical management of obese patients. Second, our population-level analyses of EHR-documented outcomes might have led us to conclude that the form had no affect whatsoever on clinician behaviors or patient outcomes. Only the realization that the form had such minimal clinician uptake and limited patient exposure prompted us to evaluate outcomes in the small subpopulation of patients whose encounters could potentially be influenced by exposure to the form.
In follow-up discussions with clinicians and the directors of the FQHC, we explored reasons for the form's low uptake. Several explanations emerged, including the complex navigation pathway needed to locate the form in the EHR, minimal training, and the perceived time burden required to learn and use the form. These barriers, consistent with those encountered in other EHR interventions, 31 highlight challenges associated with implementing interventions in a complex care system. Additionally, our conceptualization of clinic workflow did not sufficiently consider the role of the MA or nurse in the new obesity protocol's workflow. The protocol specified that the MA or nurse identify an obese patient at intake by weighing them and entering their data into the EHR. Then, while rooming the patient, the MA or nurse was to give the patient a hardcopy of the Health Behavior Change Checklist (Appendix A) to complete before meeting with the clinician. The clinician was then to discuss weight management and enter the patient's endorsed goals into the weight management form in the EHR. However, because scales were in high demand at intake, the MA or nurse frequently lacked time to enter the patient's weight until after rooming the individual. This led to cases of obesity being overlooked and patients not being given the hardcopy of the Checklist, for which completion rates were not recorded.
These implementation challenges highlight some of the difficulties involved in performing community-based research. Unlike wellcontrolled efficacy trials, effectiveness interventions must adapt to real-world settings by implementing programs that fit into pre-existing infrastructures and work flows.
Despite these limitations and challenges, the study provided evidence to suggest that an EHR intervention guided by the 5As framework to prompt assessment and counseling for adult obesity may improve obesity management by enhancing clinician weight-loss counseling. Additionally, clinicians believed that the form increased their communication about modifiable risk behaviors and increased their confidence about helping patients to manage weight.
Given these reported benefits and the need to document behavioral counseling in accord with the Centers for Medicare and Medicaid Services policy memorandum, 21 it is important for future studies to examine digital tools and systems that can facilitate the 5As of obesity treatment even more strongly. Because EHR-supported obesity interventions utilize digital tools embedded in a complex care system, their impact may be increased by efforts to enhance stakeholder engagement and systematic training, better integrate into clinic workflow, design more easily-accessible EHR tools, and allow sufficient time for uptake. 32 EHR-based interventions warrant evaluation for their impact at two levels, for clinician performance and for patient outcomes, to learn whether modifications in clinician behavior translate to changes in patient outcomes.
CONCLUSIONS
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